However, OXA also reduced the expression of CD24 and CD44, which are specific surface markers for colon cancer stem cells, while TP5 mildly enabled OXA to exert an inhibitory effect on stem cell stemness. The gene discussed is CD44; the disease is colonic neoplasm.